005 |
|
20221024113817.0 |
010 |
|
|a 2008000008
|
020 |
|
|a0781774241 (alk. paper)
|
020 |
|
|a9780781774246 (alk. paper)
|
040 |
|
|aDNLM/DLC|cDLC|dDLC|dNOU
|
050 |
00
|
|aRM301.25|b.S693 2009
|
060 |
10
|
|aQV 744|bS756g 2009
|
082 |
00
|
|a615/.19|222
|
100 |
1
|
|aSpilker, Bert.
|
245 |
10
|
|aGuide to drug development|h[electronic resource] :|ba comprehensive review & assessment /|cBert Spilker.
|
260 |
|
|aPhiladelphia :|bWolters Kluwer/Lippincott Williams & Wilkins Health,|cc2009.
|
263 |
|
|a0807
|
300 |
|
|ap. ;|ccm.
|
504 |
|
|aIncludes bibliographical references and index.
|
533 |
|
|aElectronic reproduction.|bNew York, N.Y. :|cOvid Technologies, Inc.|nAvailable via World Wide Web.
|
650 |
0
|
|aDrug development.
|
650 |
12
|
|aDrug Design.
|
650 |
22
|
|aDrug Evaluation, Preclinical|xmethods.
|
650 |
22
|
|aDrug Industry|xmethods.
|
650 |
22
|
|aPharmaceutical Preparations.
|
710 |
2
|
|aOvid Technologies, Inc.
|
809 |
|
|pEB|dRM301.25|eS756|y2009
|
856 |
40
|
|aE-Books (Ovid)|zAuthentication may be required:|uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=booktext&NEWS=N&DF=bookdb&AN=01337530/1st_Edition&XPATH=/PG(0)
|